Global Health Stock EBITDA
| GLH Stock | 0.14 0.01 7.69% |
Global Health fundamentals help investors to digest information that contributes to Global Health's financial success or failures. It also enables traders to predict the movement of Global Stock. The fundamental analysis module provides a way to measure Global Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Global Health stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -1.8 M | -1.7 M |
Global | EBITDA |
Global Health Company EBITDA Analysis
Global Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Global Health EBITDA | (1.77 M) |
Most of Global Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Global Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Global Ebitda
Ebitda |
|
According to the company disclosure, Global Health reported earnings before interest,tax, depreciation and amortization of (1.77 Million). This is much lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The ebitda for all Australia stocks is notably higher than that of the company.
Global EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Global Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Global Health could also be used in its relative valuation, which is a method of valuing Global Health by comparing valuation metrics of similar companies.Global Health is currently under evaluation in ebitda category among its peers.
Global Fundamentals
| Return On Equity | -13.59 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 6.8 M | ||||
| Shares Outstanding | 58.05 M | ||||
| Shares Owned By Insiders | 77.53 % | ||||
| Shares Owned By Institutions | 3.10 % | ||||
| Price To Book | 2.66 X | ||||
| Price To Sales | 0.91 X | ||||
| Revenue | 8.12 M | ||||
| Gross Profit | 511.21 K | ||||
| EBITDA | (1.77 M) | ||||
| Net Income | (1.31 M) | ||||
| Total Debt | 1.03 M | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | (1.13 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Beta | 0.32 | ||||
| Market Capitalization | 7.84 M | ||||
| Total Asset | 3.08 M | ||||
| Retained Earnings | (30.68 M) | ||||
| Working Capital | (1.58 M) | ||||
| Net Asset | 3.08 M |
About Global Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Global Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Global Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Global Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Global Stock Analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.